FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Margarita Carmona

Research Profile

Chemicals & Drugs

Disorders

Procedures

Immunohistochemistry

Anatomy

Phenomena

Physiology

DNA Fragmentation

Co-author Network

Publications

TOP 3
Ester Aso; Margarita Carmona; Mario Díaz; Núria Fernández-Yagüe; Laura Joda; Salvador Juvés; Selene Lomoio; Irene López-González; Virginia Martín; Jesús Moreno; Reinald Pamplona; Manuel Portero-Otin; Aurora Pujol; Isidro Ferrer
Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.
Isidre Ferrer; Anna Martinez; Rosa Blanco; Esther Dalfó; Margarita Carmona
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Anna Martinez; Margarita Carmona; Manuel Portero-Otin; Alba Naudí; Reinald Pamplona; Isidre Ferrer
Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Margarita Carmona (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ester Aso; Margarita Carmona; Mario Díaz; Núria Fernández-Yagüe; Laura Joda; Salvador Juvés; Selene Lomoio; Irene López-González; Virginia Martín; Jesús Moreno; Reinald Pamplona; Manuel Portero-Otin; Aurora Pujol; Isidro Ferrer
Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease.
Brain pathology (Zurich, Switzerland) 2012;22(5):636-53.
2011: Isidre Ferrer; Anna Martinez; Rosa Blanco; Esther Dalfó; Margarita Carmona
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Journal of neural transmission (Vienna, Austria : 1996) 2011;118(5):821-39.
2008: Anna Martinez; Margarita Carmona; Manuel Portero-Otin; Alba Naudí; Reinald Pamplona; Isidre Ferrer
Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.
Journal of neuropathology and experimental neurology 2008;67(12):1122-36.
2007: Isidro Ferrer; Gabriel Santpere; Thomas Arzberger; Jeanne Bell; Rosa Blanco; Susana Boluda; Herbert Budka; Margarita Carmona; Giorgio Giaccone; Bjarne Krebs; Lucia Limido; Piero Parchi; Berta Puig; Rosaria Strammiello; Thomas Ströbel; Hans A Kretzschmar
Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study.
Journal of neuropathology and experimental neurology 2007;66(1):35-46.
2004: Isidro Ferrer; M Freixas; Rosa Blanco; Margarita Carmona; Berta Puig
Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Neuropathology and applied neurobiology 2004;30(4):329-37.
2003: Isidro Ferrer; Marta Barrachina; M Tolnay; María Jesús Rey; Noemi Vidal; Margarita Carmona; Rosa Blanco; Berta Puig
Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Brain pathology (Zurich, Switzerland) 2003;13(1):62-78.
2002: Isidro Ferrer; Rosa Blanco; Margarita Carmona; Berta Puig; I Domínguez; F Viñals
Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Acta neuropathologica 2002;103(4):391-407.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona
Differential expression of active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates following quinolinic acid excitotoxicity in the rat.
Brain research. Molecular brain research 2001;94(1-2):48-58.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona; Berta Puig
Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Neuropathology and applied neurobiology 2001;27(5):343-51.
2001: Isidro Ferrer; Berta Puig; J Krupinsk; Margarita Carmona; Rosa Blanco
Fas and Fas ligand expression in Alzheimer's disease.
Acta neuropathologica 2001;102(2):121-31.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona; R Ribera; E Goutan; Berta Puig; María Jesús Rey; A Cardozo; F Viñals; T Ribalta
Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Brain pathology (Zurich, Switzerland) 2001;11(2):144-58.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona; Berta Puig
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(12):1397-415.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona; Berta Puig; Marta Barrachina; C Gómez; Santiago Ambrosio
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(12):1383-96.
2001: Isidro Ferrer; Rosa Blanco; Margarita Carmona; Berta Puig; R Ribera; María Jesús Rey; T Ribalta
Prion protein expression in senile plaques in Alzheimer's disease.
Acta neuropathologica 2001;101(1):49-56.